| The potential of cell-penetrating peptides for mRNA delivery to cancer cells Y Kim, H Kim, EH Kim, H Jang, Y Jang, SG Chi, Y Yang, SH Kim Pharmaceutics 14 (6), 1271, 2022 | 32 | 2022 |
| mRNA: A promising platform for cancer immunotherapy B Kong, Y Kim, EH Kim, JS Suk, Y Yang Advanced Drug Delivery Reviews, 114993, 2023 | 27 | 2023 |
| Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma DW Jeong, JW Park, KS Kim, J Kim, J Huh, J Seo, YL Kim, JY Cho, ... Nature communications 14 (1), 6370, 2023 | 19 | 2023 |
| Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy Y Kim, J Choi, EH Kim, W Park, H Jang, Y Jang, SG Chi, DH Kweon, ... Advanced Science, 2309917, 2024 | 16 | 2024 |
| Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery H Jang, H Kim, EH Kim, G Han, Y Jang, Y Kim, JW Lee, SC Shin, EEK Kim, ... Biomaterials Research 27 (1), 124, 2023 | 13 | 2023 |
| The effect of neddylation blockade on slug-dependent cancer cell migration is regulated by p53 mutation status Y Kim, JB Park, J Fukuda, M Watanabe, YS Chun Cancers 13 (3), 531, 2021 | 13 | 2021 |
| Kdm3b haploinsufficiency impairs the consolidation of cerebellum-dependent motor memory in mice YG Kim, MS Bak, A Kim, Y Kim, YC Chae, YL Kim, YS Chun, JY An, ... Molecular brain 14, 1-11, 2021 | 5 | 2021 |
| Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death EH Kim, J Choi, H Jang, Y Kim, JW Lee, Y Ryu, J Choi, Y Choi, SG Chi, ... Theranostics 14 (10), 3777, 2024 | 3 | 2024 |
Yoosoo YangKorea Institute of Science and Technology在 kist.re.kr 的电子邮件经过验证
Yoosoo YangKorea Institute of Science and Technology在 kist.re.kr 的电子邮件经过验证
SUN HWA KIMKorea Institute of Science and Technology在 kist.re.kr 的电子邮件经过验证